Metropolitan Life Insurance Company (MetLife)’s Stem STEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-216
Closed -$9.45K 1848
2024
Q1
$9.45K Sell
216
-181
-46% -$10.1K ﹤0.01% 2149
2023
Q4
$30.8K Hold
397
﹤0.01% 1707
2023
Q3
$33.6K Hold
397
﹤0.01% 1616
2023
Q2
$45.4K Hold
397
﹤0.01% 1479
2023
Q1
$45K Sell
397
-50
-11% -$8.47K ﹤0.01% 1443
2022
Q4
$79.9K Hold
447
﹤0.01% 1189
2022
Q3
$119K Hold
447
0.01% 919
2022
Q2
$64K Buy
447
+67
+18% +$11.1K ﹤0.01% 1334
2022
Q1
$83.7K Sell
380
-1,129
-75% -$263K ﹤0.01% 1315
2021
Q4
$572K Buy
1,509
+836
+124% +$362K 0.01% 1331
2021
Q3
$322K Sell
673
-221
-25% -$116K ﹤0.01% 1723
2021
Q2
$644K Buy
+894
New +$487K 0.01% 1344

Other funds holding STEM

Metropolitan Life Insurance Company (MetLife)'s STEM Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Stem (STEM) in Q2 2024, closing a stake of 216 shares — an estimated $9.45K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in STEM in Q2 2021 and held it in 12 quarters. The position peaked at $644K in Q2 2021. 182 funds tracked by Wall St. Rank hold STEM as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Stem position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 216 Stem shares in Q2 2024, an estimated $9.45K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Stem in Q2 2021 and held it in 12 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Stem position peaked at $644K in Q2 2021.
  • 182 funds tracked by Wall St. Rank held Stem as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.